Potentiation of Glucocorticoid Receptor Transcriptional Activity by Sumoylation
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The glucocorticoid receptor (GR) is a transcription factor, subject to several types of posttranslational modifications including phosphorylation and ubiquitination. We showed that the GR is covalently modified by the small ubiquitin-related modifier-1 (SUMO-1) peptide in mammalian cells. We demonstrated that GR sumoylation is not dependent on the presence of the ligand and regulates the stability of the protein as well as its transcriptional activity. SUMO-1 overexpression induces dramatic GR degradation, abolished by proteasome inhibition. We also found that SUMO-1 stimulates the transactivation capacity of GRs to an extent largely exceeding those observed so far for other sumoylated transcription factors. Overexpression of SUMO-1 specifically enhances the ligand-induced transactivation of GR up to 8-fold. However, this hyperactivation occurs only in the context of a synergy between multiple molecules of GRs. It requires more than one receptor DNA-binding site in promoter and becomes more prominent as the number of sites increases. Interestingly, these observations may be related to the transcriptional properties of the synergy control region of GRs, which precisely contains two evolutionary conserved sumoylation sites. We propose a model in which SUMO-1 regulates the synergy control function of GR and serves as a unique signal for activation and destruction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sumoylation of GRα has been shown to promote its degradation and inhibits the transcriptional activity of GR in a promoter-specific manner by recruiting corepressors81.”
From Corticosteroids (2016) · cites this paper as [81]
In the citing paper
“GR is sumoylated at residues Lys-277, Lys-293 and Lys-703 (Fig.3B).”
From Corticosteroids (2016) · cites this paper as [81]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3
Saitoh, H., & Hinchey, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6252 · Cited by 895
The glucocorticoid receptor: rapid exchange with regulatory sites in living cells
McNally, J. G., Müller, W. G., Walker, D., Wolford, R., & Hager, G. L. (2000) · Science · doi:10.1126/science.287.5456.1262 · Cited by 802
Melchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
Rodriguez, M. S., Dargemont, C., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009476200 · Cited by 744
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Cited by
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
Gill, G. (2004) · Genes & Development · doi:10.1101/gad.1214604 · Cited by 756
“Strikingly, mutation of the SUMO acceptor site in GR or overexpression of SUMO-1 has been shown to increase activity from some GR target promoters but not others (Le Drean et al. 2002; Tian et al. 2002; Holmstrom et al. 2003).”
BackgroundRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Nuclear and unclear functions of SUMO
Seeler, J.-S., & Dejean, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1200 · Cited by 667
“By contrast, GR-mediated activation is reduced by sumoylation when assayed on single-site reporters, whereas some promoters with multiple binding sites lead to enhancement of synergy following sumoylatio”
BackgroundGlucocorticoid receptor control of transcription: precision and plasticity via allostery
Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.152 · Cited by 533
The human glucocorticoid receptor: molecular basis of biologic function
Nicolaides, N. C., Galata, Z., Kino, T., Chrousos, G. P., & Charmandari, E. (2010) · Steroids · doi:10.1016/j.steroids.2009.09.002 · Cited by 436
Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
The human glucocorticoid receptor: One gene, multiple proteins and diverse responses
ZHOU, J., & CIDLOWSKI, J. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.006 · Cited by 372
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
“Although SUMOylation of GR can occur in a ligand-independent manner and does not require an intact GR LBD and DBD dimerization motif, the integrity of the latter domains and especially binding of GR to DNA appears necessary to implement SUMO-dependent transcriptional inhibition (360, 362).”
BackgroundSUMO: a regulator of gene expression and genome integrity
Müller, S., Ledl, A., & Schmidt, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207415 · Cited by 283
“It is noteworthy, however, that in some contexts, the SUMO system has been shown to activate steroid receptors (Le Drean et al., 2002).”
BackgroundJürgen Dohmen, R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.021 · Cited by 270
Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification
Duma, D., Jewell, C. M., & Cidlowski, J. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.009 · Cited by 267
Comprehensive Overview of the Structure and Regulation of the Glucocorticoid Receptor
Vandevyver, S., Dejager, L., & Libert, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1010 · Cited by 265
Glucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248
Sumoylation of the Estrogen Receptor α Hinge Region Regulates Its Transcriptional Activity
Sentis, S., Le Romancer, M., Bianchin, C., Rostan, M.-C., & Corbo, L. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0042 · Cited by 237
Gill, G. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00021-2 · Cited by 226
Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling
Revollo, J. R., & Cidlowski, J. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04986.x · Cited by 220
The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms
LU, N. Z., & CIDLOWSKI, J. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.008 · Cited by 216
Post-translational modifications of steroid receptors
Faus, H., & Haendler, B. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.082 · Cited by 209
Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., & Taylor, C. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337412100 · Cited by 185
Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 181
Acetylation of nuclear receptors in cellular growth and apoptosis
Fu, M., Wang, C., Zhang, X., & Pestell, R. G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.037 · Cited by 182
SUMO Modification of STAT1 and Its Role in PIAS-mediated Inhibition of Gene Activation
Rogers, R. S., Horvath, C. M., & Matunis, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301344200 · Cited by 174
Cheng, J., Wang, D., Wang, Z., & Yeh, E. T. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6021-6028.2004 · Cited by 173
“A large number of sumoylated proteins, including RanGAP1, PML, I B , p53, c-Jun, Sp3, Elk-1, p300, and many nuclear receptors, have been identified (8, 9, 15, 20, 29, 33, 38, 41, 48, 49).”
BackgroundGalliher-Beckley, A. J., Williams, J. G., & Cidlowski, J. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05866-11 · Cited by 164
“There are several mechanisms for expanding the plasticity of glucocorticoid signaling, including receptor isoforms and posttranslational modifications, such as phosphorylation, ubiquitination, and SUMOylation (23, 29, 43).”
BackgroundLing, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh195 · Cited by 155
Holmstrom, S., Van Antwerp, M. E., & Iñiguez-Lluhí, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136933100 · Cited by 154
Yamashita, D., Yamaguchi, T., Shimizu, M., Nakata, N., Hirose, F., & Osumi, T. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00786.x · Cited by 139
“In the glucocorticoid receptor case, the effect of SUMO-1 over-expression (Le Drean et al. 2002) or sumoylation-defective mutation (Tian et al. 2002) varies with the promoter.”
BackgroundGlucocorticoids in the regulation of transcription factors that control cytokine synthesis
Liberman, A. C., Druker, J., Perone, M. J., & ARZT, E. S. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.005 · Cited by 148
“Accordingly, GR is modified by SUMO and this covalent modification regulates the stability of the GR and potentiates its transactivation activity [98].”
BackgroundLoison, F., Debure, L., Nizard, P., le Goff, P., Michel, D., & le Dréan, Y. (2006) · Biochemical Journal · doi:10.1042/bj20051190 · Cited by 126
Hirano, Y., Murata, S., Tanaka, K., Shimizu, M., & Sato, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212448200 · Cited by 110
Optimized glucocorticoid therapy: teaching old drugs new tricks
Strehl, C., & Buttgereit, F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.026 · Cited by 118
Kaikkonen, S., Jääskeläinen, T., Karvonen, U., Rytinki, M. M., Makkonen, H., Gioeli, D., Paschal, B. M., & Palvimo, J. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0219 · Cited by 115
Vigodner, M., & Morris, P. L. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.03.034 · Cited by 116
Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function
Davies, L., Karthikeyan, N., Lynch, J. T., Sial, E.-A., Gkourtsa, A., Demonacos, C., & Krstic-Demonacos, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0360 · Cited by 109
Modulation of Steroid Hormone Receptor Activity
Stanišić, V., Lonard, D. M., & O’Malley, B. W. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81009-6 · Cited by 118
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
Opitz, C. A., Holfelder, P., Prentzell, M. T., & Trump, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115798 · Cited by 121
Cagnin, S., Biscuola, M., Patuzzo, C., Trabetti, E., Pasquali, A., Laveder, P., Faggian, G. G., Iafrancesco, M., Mazzucco, A., Pignatti, P. F., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-13 · Cited by 100
“In addition, we evidenced the down-regulation of SUMO1 both in coronary and carotid samples, and it is known that GR are activated by sumoylation[13].”
BackgroundSUMO wrestling with type 1 diabetes
Li, M., Guo, D., Isales, C. M., Eizirik, D. L., Atkinson, M. A., She, J., & Wang, C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0645-5 · Cited by 96
“Recent studies revealed that sumoylation plays a pivotal role in the regulation of GR transcriptional synergy in the context of the subset of target genes containing multiple GREs (glucocorticoid-response element) [95, 96].”
PIASy-Deficient Mice Display Modest Defects in IFN and Wnt Signaling
Roth, W., Sustmann, C., Kieslinger, M., Gilmozzi, A., Irmer, D., Kremmer, E., Turck, C. W., & Grosschedl, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6189 · Cited by 104
Coactivation of the N-terminal Transactivation of Mineralocorticoid Receptor by Ubc9
Yokota, K., Shibata, H., Kurihara, I., Kobayashi, S., Suda, N., Murai-Takeda, A., Saito, I., Kitagawa, H., Kato, S., Saruta, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607741200 · Cited by 85
Lin, D.-Y., Lai, M., Ann, D. K., & Shih, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300387200 · Cited by 85
Wang, Y.-T., Chuang, J., Shen, M., Yang, W., Chang, W., & Hung, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.043 · Cited by 83
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 90
Broday, L., Kolotuev, I., Didier, C., Bhoumik, A., Gupta, B. P., Sternberg, P. W., Podbilewicz, B., & Ronai, Z. A. (2004) · Genes & Development · doi:10.1101/gad.1227104 · Cited by 78
Sionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 88
“In addition to phosphorylation, other post‐translational modifications such as ubiquitylation, acetylation, and sumoylation may regulate GR function (Duma et al., 2006; Holmstrom et al., 2003; Le Drean et al., 2002; Tian et al., 2002; Wallace and Cidlowski, 2001).”
BackgroundInfluentialGlucocorticoid therapy and ocular hypertension
Dibas, A., & Yorio, T. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.018 · Cited by 75
“Sumoylation of GRα dramatically promotes its degradation and inhibits the transcriptional activity of the receptor in a promoter-dependent fashion through the recruitment of corepressors (Davies et al., 2008; Holmstrom et al., 2003, 2008; Le Drean et al., 2002; and Lin et al., 2006).”
BackgroundGuo, B., & Sharrocks, A. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01128-08 · Cited by 89
“PEA3(1-480)] and its mutant derivatives were used.”
BackgroundCallewaert, L., Verrijdt, G., Haelens, A., & Claessens, F. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0313 · Cited by 72
Control of Peroxisome Proliferator‐Activated Receptor γ2 Stability and Activity by SUMOylation
Floyd, Z. E., & Stephens, J. M. (2004) · Obesity Research · doi:10.1038/oby.2004.112 · Cited by 71
Targeting the PIAS1 SUMO ligase pathway to control inflammation
Liu, B., & Shuai, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.008 · Cited by 70
Choi, S. J., Chung, S. S., Rho, E. J., Lee, H. W., Lee, M. H., Choi, H., Seol, J. H., Baek, S. H., Bang, O. S., & Chung, C. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604033200 · Cited by 85
Overview of the structural basis for transcription regulation by nuclear hormone receptors
Kumar, R., Johnson, B. H., & Thompson, E. B. (2004) · Essays in Biochemistry · doi:10.1042/bse0400027 · Cited by 65
“The effect on structure is unknown, but sumoylation may affect transcriptional transactivation efficiency and possibly nuclear localization [9].”
Mechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 82
“hances its transactivational activity [107].”
Gender Bias in Human Systemic Lupus Erythematosus: A Problem of Steroid Receptor Action?
Rider, V., Abdou, N. I., Kimler, B. F., Lu, N., Brown, S. J., & Fridley, B. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00611 · Cited by 75
“org March 2018 | Volume 9 | Article 611 SUMO modification of ERα and GR alters protein–protein interactions and transcriptional profiles (25, 28, 50).”
Glucocorticoid Receptor Signaling in Diabetes
Kokkinopoulou, I., Diakoumi, A., & Moutsatsou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011173 · Cited by 70
Glucocorticoid receptor signaling and prostate cancer
Kassi, E. N., & Moutsatsou, P. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.020 · Cited by 69
“Sumoylation of the GR affects both transcriptional activation and protein stability [39].”
BackgroundInducible COX-2-dependent apoptosis in human ovarian cancer cells
Lin, C., Crawford, D. R., Lin, S., Hwang, J., Sebuyira, A., Meng, R., Westfall, J. E., Tang, H., Lin, S., Yu, P.-Y., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq212 · Cited by 58
Tirard, M., Almeida, O. F. X., Hutzler, P., Melchior, F., & Michaelidis, T. M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.01.010 · Cited by 68
“Such a model would explain the previously reported, opposing effects of SUMO-1 on the transcriptional activity of GR (Le Drean et al., 2002, Tian et al., 2002) and the failure of SUMO-1 overexpression to influence the activity of the intact MR in our system.”
BackgroundResultSumoylation Modulates the Assembly and Activity of the Pre-mRNA 3′ Processing Complex
Vethantham, V., Rao, N., & Manley, J. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01186-07 · Cited by 59
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
Noureddine, L. M., Trédan, O., Hussein, N., Badran, B. M., Romancer, M. L., & Poulard, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094446 · Cited by 59
“Additionally, sumoylation of GR at K277, K293, and K703, catalyzed by SUMO-1conjugating E2 enzyme Ubc9, can regulate GR transcriptional activity on specific subsets of GR target genes [84,85].”
BackgroundDisease- and treatment-associated acquired glucocorticoid resistance
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0421 · Cited by 58
Xu, Y. J., Ikegami, M., Wang, Y., Matsuzaki, Y., & Whitsett, J. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-455 · Cited by 53
“SUMO1 can covalently modify many targets including STAT1 and glucocorticoid receptor NR3C1 (increased 5 fold) and regulate protein stability and transcriptional activity [30].”
BackgroundRSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity
Druker, J., Liberman, A. C., Antunica-Noguerol, M., Gerez, J., Páez-Pereda, M., Rein, T., Iñiguez-Lluhí, J. A., Holsboer, F., & ARZT, E. S. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01470-12 · Cited by 63
“SUMO modification of GR has a strong influence on its transcriptional activity (8, 11, 21).”
BackgroundSmith, M. D., Bhaskar, V., Fernandez, J., & Courey, A. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404942200 · Cited by 51
Cho, S., Kagan, B. L., Blackford, J. A., Szapary, D., & Simons, S. S. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0134 · Cited by 52
Mode of Glucocorticoid Actions in Airway Disease
Ito, K., Getting, S., & Charron, C. E. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.274 · Cited by 54
“SUMO-1 modification of GR regulates the stability of the protein and also enhances the ligand-induced transactivation of GR[92].”
BackgroundEnhancement of Transactivation Activity of Rta of Epstein-Barr Virus by RanBPM
Chang, L.-K., Liu, S., Kuo, C.-W., Wang, W., Chuang, J., Bianchi, E., & Hong, Y. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.011 · Cited by 48
Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation
Abdel-Hafiz, H. A., Dudevoir, M. L., & Horwitz, K. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805226200 · Cited by 53
Kurihara, I., Shibata, H., Kobayashi, S., Suda, N., Ikeda, Y., Yokota, K., Murai, A., Saito, I., Rainey, W. E., & Saruta, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411820200 · Cited by 46
Zheng, Z., Cai, C., Omwancha, J., Chen, S., Baslan, T., & Shemshedini, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509260200 · Cited by 49
Matić, G., Milutinović, D. V., Nestorov, J., Elaković, I., Jovanović, S. M., Perišić, T., Dunđerski, J., Damjanović, S., Knežević, G., Špirić, Ž., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.005 · Cited by 43
“It is known that GR is subject to mono- and polysumoylation (Le Drean et al., 2002), which regulates the stability of the receptor protein and influences its transcriptional activity (Holmstrom et al., 2003).”
BackgroundShah, R., Alvarez, M. B., Jones, D. R., Torrungruang, K., Watt, A. J., Selvamurugan, N., Partridge, N. C., Quinn, C. O., Pavalko, F. M., Rhodes, S. J., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00517.2003 · Cited by 50
“These domains are thought to recruit synergy control factors, and one such candidate is SUMO, a ubiquitin-like protein that may limit higherorder interactions among the transcription factors within the enhanceosome (19, 32).”
GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
Louw, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01693 · Cited by 46
Zhadobov, M., Sauleau, R., Le Coq, L., Debure, L., Thouroude, D., Michel, D., & Le Dréan, Y. (2007) · Bioelectromagnetics · doi:10.1002/bem.20285 · Cited by 38
Self-citationShao, R., Zhang, F.-P., Rung, E., Palvimo, J. J., Huhtaniemi, I., & Billig, H. (2004) · Endocrinology · doi:10.1210/en.2003-0527 · Cited by 36
Tirard, M., Jasbinsek, J., Almeida, O., & Michaelidis, T. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320825 · Cited by 36
Cardiac function and disease: emerging role of small ubiquitin‐related modifier
Wang, J. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.130 · Cited by 40
Sato, Y., Miyake, K., Kaneoka, H., & Iijima, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600852200 · Cited by 37
Arango-Lievano, M., & Jeanneteau, F. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.005 · Cited by 41
SUMO and estrogen receptors in breast cancer
Karamouzis, M., Konstantinopoulos, P., Badra, F. A., & Papavassiliou, A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9552-5 · Cited by 38
“[93], PR [94], glucocorticoid receptor (GR) [95], peroxisome proliferator-activated receptor c (PPARc) [96], rexinoid receptor a (RXRa) [97]) as well as for”
BackgroundKumar, R. (2008) · Biologics: Targets & Therapy · doi:10.2147/btt.s3820 · Cited by 34
Intracellular Molecular Signaling: Basis for Specificity to Glucocorticoid Anti‐inflammatory Actions
Liberman, A. C., Druker, J., Aprile-Garcia, F., Holsboer, F., & ARZT, E. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03958.x · Cited by 39
Spies, L.-M. L., Verhoog, N. J. D., & Louw, A. (2021) · Cells · doi:10.3390/cells10102529 · Cited by 37
Kobayashi, S., Shibata, H., Kurihara, I., Yokota, K., Suda, N., Saito, I., & Saruta, T. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320069 · Cited by 31
“Recent data have raised the intriguing possibility that SUMO modification may have a specific impact on the ability of some transcription factors to function synergistically (Iniguez-Lluhi & Pearce 2000, Le Drean et al. 2002, Verger et al. 2003).”
BackgroundRole of SUMOylation in Full Antiestrogenicity
Hilmi, K., Hussein, N., Mendoza‐Sanchez, R., Ezzy, M. E., Ismail, H., Durette, C., Bail, M., Rozendaal, M. J., Bouvier, M., Thibault, P., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00290-12 · Cited by 38
“One study reported that SUMOylation potentiates the transcriptional activity of agonistbound glucocorticoid receptor (GR) (46), whereas other studies concluded that SUMOylation represses transcription induced by GR, the progesterone receptor, and the androgen receptor (1, 60, 68, 86).”
BackgroundNuclear receptor coregulators: their modification codes and regulatory mechanism by translocation
Baek, S. H., & Rosenfeld, M. G. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.169 · Cited by 39
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation
Abdel-Hafiz, H. A., & Horwitz, K. B. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-10 · Cited by 30
“Wild-type SENP1 does not have a repressive effect on the weak ligand-dependent transcription of DBD-LBD (Figure 4B); likely the target of different, possibly non-SUMOylated, C-terminal interacting coregulators.”
BackgroundInfluentialTranscription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2α
Yamashita, D., Moriuchi, T., Osumi, T., & Hirose, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713370 · Cited by 30
SUMO-1 of mud crab (Scylla paramamosain) in gametogenesis
Dai, Y., Han, K., Zou, Z., Yan, S., Wang, Y., & Zhang, Z. (2012) · Gene · doi:10.1016/j.gene.2012.04.056 · Cited by 26
Kim, Y. Y., Sun, Y., Chow, C. C., Pommier, Y. G., & Simons, S. S. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.003 · Cited by 26
PML bodies in reactive sensory ganglion neurons of the Guillain–Barré syndrome
Villagrá, N. T., Berciano, J., Altable, M., de Navascués, J., Casafont, Í., Lafarga, M., & Berciano, M. T. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.02.005 · Cited by 23
Minireview: What is Known about SUMOylation Among NR4A Family Members?
Dodat, F., Mader, S., & Lévesque, D. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167212 · Cited by 23
Priyanka, P., Kotiya, D., Rana, M., Subbarao, N., Puri, N., & Tyagi, R. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.001 · Cited by 22
Regulation of bcl-2 expression by Ubc9
Lu, Z., Wu, H., & Mo, Y. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.02.017 · Cited by 22
Ylikomi, T. J., Vienonen, A., & Ahola, T. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04353.x · Cited by 22
Ubiquitin-like protein modifications in prostate and breast cancer
Wu, F., & Mo, Y.-Y. (2006) · Frontiers in bioscience · doi:10.2741/2094 · Cited by 27
“(PPARγ) are subjected to SUMO modification (87-91).”
Metadata
- Authors
- Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Michel, Denis
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-09
- Volume
- 143
- Issue
- 9
- Pages
- 3482-3489
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2007938731
- Cited by
- 159
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 10 · 2012: 8
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- glucocorticoid receptor, SUMOylation, SUMO1, transcriptional activation, protein stability, proteasomal degradation, post-translational modification, transcription factor regulation
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, DNA, Drug Stability, Drug Synergism, Cricetinae, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Fusion Proteins, Structure-Activity Relationship, Transcription, Genetic, Transfection, Transcriptional Activation, Gene Expression, Sequence Alignment, CHO Cells, COS Cells, SUMO-1 Protein, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.